1	Los	el	DA0MP0	-	-	0-3	322(3)_ANS_clinical_caseMIR	SENT1	-	-
2	inhibidores	inhibidor	NCMP000	-	-	4-15	322(3)_ANS_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	16-18	322(3)_ANS_clinical_caseMIR	SENT1	-	-
4	la	lo	PP3FSA00	-	-	19-21	322(3)_ANS_clinical_caseMIR	SENT1	-	-
5	enzima	enzima	NCCS000	C0014442	sustancia	22-28	322(3)_ANS_clinical_caseMIR	SENT1	-	-
6	convertidora	convertidor	AQ0FS0	-	-	29-41	322(3)_ANS_clinical_caseMIR	SENT1	-	-
7	de	de	SPS00	C0332285	atributo	42-44	322(3)_ANS_clinical_caseMIR	SENT1	-	-
8	la	lo	PP3FSA00	-	-	45-47	322(3)_ANS_clinical_caseMIR	SENT1	-	-
9	angiotensina	angiotensina	NCFS000	C0003018	sustancia	48-60	322(3)_ANS_clinical_caseMIR	SENT1	-	-
10	se	se	P00CN000	-	-	61-63	322(3)_ANS_clinical_caseMIR	SENT1	-	-
11	utilizan	utilizar	VMIP3P0	-	-	64-72	322(3)_ANS_clinical_caseMIR	SENT1	-	-
12	de	de	SPS00	C0332285	atributo	73-75	322(3)_ANS_clinical_caseMIR	SENT1	-	-
13	forma	forma	NCFS000	C0348078	atributo	76-81	322(3)_ANS_clinical_caseMIR	SENT1	-	-
14	rutinaria	rutinario	AQ0FS0	-	-	82-91	322(3)_ANS_clinical_caseMIR	SENT1	-	-
15	para	para	SPS00	C0521125	calificador	92-96	322(3)_ANS_clinical_caseMIR	SENT1	-	-
16	prevenir	prevenir	VMN0000	-	-	97-105	322(3)_ANS_clinical_caseMIR	SENT1	-	-
17	su	su	DP3CS0	-	-	106-108	322(3)_ANS_clinical_caseMIR	SENT1	-	-
18	aparición	aparición	NCFS000	-	-	109-118	322(3)_ANS_clinical_caseMIR	SENT1	-	-
19	.	.	Fp	-	-	119-120	322(3)_ANS_clinical_caseMIR	SENT1	-	-

